Point of Care Diagnostics

Published - Nov 2016| Analyst - Jon Evans| Code - HLC043E
Point of Care Diagnostics
Single User License: $1,375 Member Price: FREE

Report Highlights

The global point of care (POC) diagnostics market was valued at nearly $16.8 billion and $18.0 billion in 2014 and 2015, respectively. This market is expected to grow from $19.3 billion in 2016 to $28.3 billion in 2021 at a compound annual growth rate (CAGR) of 8.0% for 2016-2021.

Report Includes

  • An overview of the global markets for point of care diagnostics.
  • Analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Discussion of factors driving the market including staff shortages, older populations, long-term cost savings, and need for faster diagnosis and care.
  • A look at how availability of POC testing has revolutionized the continuum of the patient-care process.
  • In depth analysis of the major force driving the growth of this industry, the effort to provide better patient care by improving the turn-around-time (TAT) that POC testing offers.
  • A look at the other market factors including growth restraints and opportunities.
  • Profiles of major players in the industry.

SCOPE OF REPORT

This study will describe the market for POC diagnostics at the global level. It focuses on the accelerating growth in this important diagnostic market segment and the key industry players. Specifically, the report:

  • Describes the POC industry. 
  • Estimates the current and future market size.
  • Provides breakdowns for U.S. markets.
  • Describes product segments and the continuous updating of POC products.
  • Analyzes market influences in the industry and predicts the changes that will shape the future POC market.
  • Discusses trends within the market and provides a future outlook. 
  • Reviews business activities of market leaders. 
  • Lists patents for POC technologies.

Analyst Credentials

JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Apr-2014| Analyst - Melissa Elder| Code - HLC043D

Report Highlights

BCC Research estimates the global market for point-of-care (POC) diagnostics to have been almost $15.1 billion in 2012. The market should reach $15.5 billion in 2013 and $19.3 billion in 2018, a compound annual growth rate (CAGR) of 4.5% over the next five years.

Report Includes

  • An overview of the global market for point of care diagnostics.
  • Analyses of global market trends, with data from 2012 and 2013, and estimates and projections of CAGRs through 2018.
  • Discussion of factors driving the market including staff shortages, older populations, long-term cost savings, and need for faster diagnosis and care.
  • A look at how availability of POC testing has revolutionized the continuum of the patient-care process.
Published - Jan-2012| Analyst - Melissa Elder| Code - HLC043C

Report Highlights

The global point-of-care (POC) diagnostics market reached $13.4 billion in 2010 and is expected to reach $13.8 billion in 2011. It will further grow to $16.5 billion in 2016 for a compound annual growth rate (CAGR) of 3.7% between 2011 and 2016.

Published - Nov-2009| Analyst - Melissa Elder| Code - HLC043B

Report Highlights

  • Global POC market was worth nearly $13.4 billion in 2009, it is estimated to increase to $18.7 billion, at 5 year compound annual growth rate (CAGR) of 7.0%.
  • The largest test blood chemistry and electrolyte market was nearly $2.1 billion in 2009. This is expected to rise to $3.8 billion in 2014, at a CAGR of 12.0%.
  • Glucose monitoring test market reached approximately $7.7 million in 2009 and is projected to reach $9.9 billion in 2014, at a CAGR of 5.1%.
Published - Feb-2006| Analyst - Barbara Breindel| Code - HLC043A

Report Highlights

  • POC testing revenue reached an estimated $5.05 billion in 2005 and is expected to grow at a 13.8% AAGR through 2010, yielding sales of nearly $9.65 billion.
  • A major force driving the growth of this industry is the effort to provide better patient care by improving the time to treatment (TAT) that POC testing offers. Other forces include cost containment, the aging population, the increased incidence of certain diseases, and technological advances.
  • Glucose testing meters and supplies accounted for 47.9% of POC sales in 2005 and are expected to grow at a 9.4% AAGR through 2010. The worldwide incidence of diabetes is predicted to double in the next 25 years.
Need Specific Data Sets?

We can tailor to your project.

Contact Us
RELATED REPORTS
Share This Report